Mannheimia Haemolytica Pneumonia

Mannheimia haemolytica pneumonia represents the most economically significant bacterial respiratory disease affecting cattle worldwide. This severe lower respiratory infection, historically known as shipping fever or pneumonic pasteurellosis, causes acute fibrinous pleuropneumonia that can rapidly progress to death without prompt treatment. The disease occurs when this opportunistic bacterium, normally present in the upper respiratory tract of healthy cattle, proliferates and invades the lungs following compromise of natural defense mechanisms by stress, viral infection, or environmental factors.

Mannheimia haemolytica pneumonia affects cattle of all ages but causes the greatest losses in young cattle undergoing stress events such as weaning, transport, commingling, and entry into feedlot environments. The disease represents the primary cause of death and treatment costs within the Bovine Respiratory Disease Complex (BRDC), which collectively accounts for more economic losses than any other health problem in the North American cattle industry. Feedlot cattle during the receiving period face the highest risk, with morbidity rates in high-risk groups sometimes exceeding 30 to 50 percent.

The economic impact of Mannheimia haemolytica pneumonia extends across all sectors of the beef industry and significantly affects dairy calf raising operations. Direct costs include mortality losses, veterinary and treatment expenses, and labor for animal care. Indirect costs often exceed direct costs and include reduced weight gain, decreased feed efficiency, increased days on feed, and reduced carcass quality in animals that survive clinical disease. Conservative estimates place annual losses from BRDC in North America at over one billion dollars, with Mannheimia haemolytica responsible for the majority of severe pneumonia cases.

Despite its severity, Mannheimia haemolytica pneumonia responds well to appropriate antimicrobial therapy when treatment is initiated early in the disease course. The development of effective vaccines and improved understanding of disease risk factors have enabled progressive reduction in losses through comprehensive prevention programs. However, the complex interplay of stress, viral co-infections, environmental conditions, and bacterial virulence factors means that complete prevention remains challenging, and rapid case identification with prompt treatment remains essential for minimizing losses in affected herds.

Mannheimia haemolytica is a gram-negative bacterium belonging to the Pasteurellaceae family that serves as the primary etiologic agent of shipping fever pneumonia in cattle. This organism normally resides as a commensal in the nasopharyngeal tonsils of healthy cattle, where it coexists harmlessly with the host. Disease occurs when predisposing factors allow the bacteria to overcome host defenses, multiply rapidly in the upper respiratory tract, and subsequently invade the lower respiratory system where they cause severe inflammatory damage. Multiple serotypes exist, with serotype A1 most commonly isolated from pneumonic cattle, though other serotypes including A2 and A6 also cause disease.

Genetic predisposition to Mannheimia haemolytica pneumonia has not been conclusively demonstrated, though individual variation in immune competence and stress resilience likely influences susceptibility. Some research suggests that certain genetic lines may mount more effective immune responses following vaccination or natural exposure. However, the overwhelming influence of environmental and management factors means that all cattle populations face significant risk when appropriate predisposing conditions occur. Bos indicus cattle and their crosses may show somewhat greater disease resistance compared to Bos taurus breeds under challenging conditions.

Environmental and management factors play the dominant role in Mannheimia haemolytica pneumonia occurrence. Transport stress, particularly long-distance hauling with inadequate rest, represents the classic predisposing factor that gave rise to the shipping fever terminology. Weaning stress, especially abrupt weaning without preconditioning, creates susceptible populations. Commingling of cattle from multiple sources exposes animals to new pathogen strains while simultaneously causing social stress. Environmental extremes including temperature fluctuations, dust, poor air quality in confined housing, and weather events such as cold rain all increase respiratory disease risk.

Risk factors for severe Mannheimia haemolytica pneumonia are well characterized and inform prevention strategies. Young cattle between six and twelve months of age face the highest risk, corresponding with the post-weaning feedlot entry period. Animals with inadequate vaccination history, poor nutritional status, or concurrent viral infections show increased susceptibility. High-risk cattle can be identified by marketing history, physical condition at arrival, and known exposure to disease in source herds. The period from 7 to 28 days after arrival at a new facility represents the peak risk window for disease development.

The pathophysiology of Mannheimia haemolytica pneumonia involves a cascade of events leading to severe lung damage. Viral infections including IBR, BVDV, BRSV, and PI3 damage the respiratory epithelium and impair mucociliary clearance and immune function, allowing bacterial proliferation. As bacteria reach the lower respiratory tract, they release leukotoxin, a potent virulence factor that destroys bovine neutrophils and macrophages attempting to clear the infection. The lysis of these immune cells releases inflammatory mediators and enzymes that cause extensive tissue damage, producing the characteristic fibrinous exudate that fills airways and consolidates lung tissue. This self-perpetuating inflammatory cycle can rapidly destroy large portions of lung tissue even after bacteria are cleared.

Early warning signs of Mannheimia haemolytica pneumonia often appear suddenly in previously healthy-appearing cattle. Initial symptoms may include subtle changes such as standing apart from the group, reluctance to come to feed, and a slightly dull appearance. Fever is typically the earliest measurable sign, with rectal temperatures often exceeding 104 to 106 degrees Fahrenheit in early disease. Experienced observers may notice slight nasal discharge, occasional coughing, or mildly elevated respiratory rate before more obvious signs develop. Early detection at this stage offers the best opportunity for successful treatment.

Common symptoms of established Mannheimia haemolytica pneumonia reflect the severe lower respiratory tract involvement characteristic of this disease. Affected cattle display obvious depression with drooping ears, dull eyes, and lack of interest in surroundings. Anorexia is pronounced, with complete refusal of feed and often water. Respiratory distress becomes increasingly apparent as disease progresses, with elevated breathing rate, labored respiration, and audible respiratory sounds. Nasal discharge transitions from clear to mucopurulent as bacterial infection becomes established. Body temperature typically remains elevated throughout acute disease.

Behavioral changes in cattle with pneumonic mannheimiosis provide important diagnostic clues for early case identification. Affected animals separate themselves from herdmates and may be found at the back of pens or in corners. They show marked reluctance to move when approached, often standing with head lowered and extended. Appetite loss is among the first behavioral changes, with sick cattle ignoring feed even when hungry pen mates are eating. Rumination ceases in severely affected animals, and the absence of normal cud-chewing activity indicates systemic illness requiring attention.

Physical signs of Mannheimia haemolytica pneumonia include multiple indicators of respiratory compromise and systemic illness. Extended head and neck posture, with elbows abducted from the chest wall, indicates respiratory distress as the animal attempts to maximize air exchange. Mouth breathing occurs in severe cases when nasal passages cannot provide adequate airflow. Thoracic auscultation reveals harsh lung sounds, crackles, and areas of absent breath sounds corresponding to consolidated lung regions. Dehydration evidenced by sunken eyes and decreased skin turgor reflects inadequate water intake and fever-related fluid losses.

Symptom progression in Mannheimia haemolytica pneumonia can be alarmingly rapid, with animals deteriorating from mildly ill to critically compromised within 12 to 24 hours. Initial fever and mild depression progress to severe respiratory distress as lung consolidation increases. Cattle may develop frothy discharge at the mouth and nostrils in terminal cases as pulmonary edema floods the airways. Cyanosis of visible mucous membranes indicates critical oxygen deprivation. Without aggressive treatment, severely affected cattle become recumbent and may die within 24 to 48 hours of first showing obvious clinical signs.

Emergency symptoms requiring immediate veterinary intervention include severe respiratory distress with open-mouth breathing and extended head and neck posture. Cyanotic or blue-tinged mucous membranes indicate life-threatening oxygen deprivation requiring emergency care. Recumbency in a pneumonic animal signals critical illness with poor prognosis. Extremely high fever exceeding 107 degrees Fahrenheit, bloody or rust-colored nasal discharge, and complete absence of gut sounds accompanying respiratory signs indicate severe systemic involvement. Any animal showing rapid deterioration despite previous treatment requires immediate veterinary reassessment and consideration of treatment intensification or humane euthanasia.

Clinical examination for Mannheimia haemolytica pneumonia relies on recognition of characteristic signs of lower respiratory infection in an appropriate risk context. Veterinary evaluation includes assessment of rectal temperature, respiratory rate and character, and auscultation of the thorax to identify abnormal lung sounds and areas of consolidation. Physical examination also evaluates hydration status, overall body condition, and concurrent problems. The history of recent stress events such as transport, weaning, or commingling provides important context for diagnosis. Clinical scoring systems have been developed to standardize assessment and guide treatment decisions in feedlot settings.

Diagnostic testing to confirm Mannheimia haemolytica infection involves several laboratory approaches. Transtracheal wash or bronchoalveolar lavage provides samples from the lower respiratory tract for bacterial culture and antimicrobial sensitivity testing. Deep nasopharyngeal swabs offer a less invasive sampling option but may reflect upper respiratory flora rather than the causative agent of pneumonia. Polymerase chain reaction testing can identify Mannheimia haemolytica and other respiratory pathogens, including detection of leukotoxin genes. Necropsy examination with lung tissue culture provides the most definitive diagnosis in fatal cases and should be pursued to guide treatment protocols for remaining at-risk animals.

Differential diagnosis for cattle presenting with pneumonia includes multiple bacterial and viral pathogens. Pasteurella multocida causes pneumonia with similar presentation though often less severe fibrinous response. Histophilus somni produces pneumonia along with potential involvement of other organ systems. Mycoplasma bovis causes chronic pneumonia with distinct characteristics described elsewhere. Viral respiratory pathogens including IBR, BVDV, BRSV, and PI3 may cause primary respiratory disease or predispose to bacterial superinfection. Aspiration pneumonia following improper oral medication administration produces similar signs with a characteristic distribution pattern in the cranioventral lung lobes.

Herd-level diagnostics support effective outbreak management and prevention program development. When multiple animals develop respiratory disease, diagnostic investigation should include sampling of both affected and in-contact cattle to characterize the pathogen population and identify viral co-infections. Antimicrobial sensitivity testing from fresh cases guides treatment protocol selection and identifies potential resistance patterns. Serology may help identify viral pathogens contributing to the outbreak. Postmortem examination of animals that die or are euthanized provides valuable information about disease processes and should be performed systematically during outbreaks to optimize treatment and prevention strategies.

Emergency and immediate treatment for cattle with severe Mannheimia haemolytica pneumonia focuses on rapid initiation of antimicrobial therapy and supportive care. Critically ill animals require immediate evaluation and treatment, as delays of even a few hours can significantly impact survival and recovery. Initial assessment should determine if the animal can safely be treated or if humane euthanasia is more appropriate based on severity of respiratory compromise and response to previous treatments. Emergency supportive measures include ensuring access to water, providing shade or shelter from environmental stressors, and minimizing handling stress.

Medical management centers on appropriate antimicrobial selection and administration. Numerous antimicrobial agents demonstrate efficacy against Mannheimia haemolytica, including macrolides such as tulathromycin, gamithromycin, and tilmicosin, fluoroquinolones such as enrofloxacin and danofloxacin, florfenicol, and cephalosporins such as ceftiofur. Selection should be guided by regional sensitivity patterns, previous treatment history of the individual and herd, labeled indications, and withdrawal time considerations for animals approaching market. Single-dose extended-release formulations offer practical advantages in reducing handling stress and ensuring adequate drug exposure. All medication use must comply with veterinary oversight requirements and food safety withdrawal periods.

Surgical intervention is not applicable to Mannheimia haemolytica pneumonia treatment, as the condition is managed medically. The disease process involves diffuse lung parenchymal damage that cannot be addressed through surgical means. In rare instances where chronic infection leads to lung abscessation, surgical drainage has been attempted but is rarely practical or successful in cattle. Focus remains entirely on antimicrobial therapy and supportive medical management.

Supportive care significantly influences treatment outcomes and should accompany antimicrobial therapy. Non-steroidal anti-inflammatory drugs such as flunixin meglumine or meloxicam reduce fever, decrease inflammation, and improve comfort, encouraging return to feed and water intake. Fluid therapy addresses dehydration in severely affected animals that have not been drinking adequately. Ensuring easy access to clean water and palatable feed encourages intake as appetite returns. Housing sick animals in a hospital pen with appropriate shelter, bedding, and reduced stocking density facilitates recovery while allowing closer monitoring and repeat treatment if needed.

Herd treatment protocols, often termed metaphylaxis, involve administering antimicrobials to all animals in high-risk groups upon arrival or at the onset of an outbreak. This approach aims to control subclinical infections before they progress to clinical disease and has demonstrated effectiveness in reducing morbidity and mortality in high-risk cattle populations. Metaphylactic treatment requires veterinary guidance to select appropriate products, timing, and target populations. While effective, judicious use principles encourage limiting metaphylaxis to situations with documented high risk and clear benefit rather than routine use in all arriving cattle.

Treatment decisions in Mannheimia haemolytica pneumonia must consider multiple factors affecting outcomes and economics. First-treatment success rates typically range from 65 to 85 percent depending on case selection and timing. Animals failing initial therapy may receive second-line treatment with alternative antimicrobial classes, though success rates decline with subsequent treatments. Chronic pneumonia cases showing repeated treatment failure and ongoing respiratory compromise may warrant salvage slaughter if withdrawal times can be met, or humane euthanasia if the animal cannot be marketed. Economic analysis should consider treatment costs, reduced performance value, and the diminishing likelihood of positive outcomes with repeated treatments when making individual animal decisions.

Recovery timeline for Mannheimia haemolytica pneumonia varies substantially based on disease severity and rapidity of treatment initiation. Cattle treated early in the disease course, before extensive lung damage occurs, often show clinical improvement within 24 to 48 hours of antimicrobial administration. Fever typically resolves within 12 to 24 hours of effective treatment, followed by gradual return of appetite and normal behavior over the subsequent two to three days. Complete clinical recovery in successfully treated cases generally requires seven to fourteen days, though lung healing continues for several weeks beyond clinical resolution.

Post-treatment care and monitoring ensure complete recovery and identify animals requiring additional intervention. Treated cattle should be observed at least twice daily for the first week following treatment, watching for persistent or recurrent fever, ongoing respiratory distress, or failure to return to feed. Animals showing inadequate response within 48 to 72 hours of initial treatment require re-evaluation for potential treatment failure or development of complications. Following apparent recovery, continued monitoring for at least two additional weeks helps identify chronic cases that may relapse or develop secondary problems.

Prognosis factors in Mannheimia haemolytica pneumonia recovery include severity of lung involvement at treatment initiation, timing of antimicrobial administration, presence of viral co-infections, and individual immune competence. Cattle treated at first signs of disease with appropriate antimicrobials carry an excellent prognosis for survival and recovery. Animals with extensive lung consolidation involving more than 30 to 40 percent of lung tissue face poorer outcomes regardless of treatment intensity. Chronic cases that fail to respond to multiple treatment attempts often develop permanent lung damage with ongoing respiratory compromise and reduced performance.

Return to production considerations must account for the permanent lung damage that follows severe Mannheimia haemolytica pneumonia. Even clinically recovered animals often retain areas of lung consolidation, adhesions, and reduced functional capacity that impact future performance. Studies consistently demonstrate that cattle treated for respiratory disease gain 0.1 to 0.2 pounds less per day than untreated contemporaries and may require additional days on feed to reach market weight. Carcass quality can be affected, with increased liver and lung condemnations at harvest. These performance impacts inform economic decisions about retained ownership versus early marketing of recovered animals.

Vaccination protocols for Mannheimia haemolytica prevention include both conventional bacterins and newer leukotoxoid-based vaccines. Traditional bacterin vaccines contain killed whole bacteria and stimulate antibody responses to multiple bacterial components. Leukotoxoid vaccines target the leukotoxin virulence factor specifically and may provide enhanced protection against the tissue-damaging effects of this critical pathogen component. Combination vaccines incorporating Mannheimia haemolytica with viral respiratory pathogens and other bacterial agents provide comprehensive respiratory disease protection. Vaccination timing ideally occurs two to four weeks before anticipated stress events, allowing adequate time for immune response development.

Biosecurity measures help prevent introduction and spread of virulent Mannheimia haemolytica strains within cattle populations. While the organism is ubiquitous in cattle, limiting exposure to novel strains through controlled sourcing and quarantine of new arrivals reduces disease risk. Avoiding commingling of cattle from multiple sources eliminates exposure to unfamiliar bacterial and viral populations. Cleaning and disinfection of transport vehicles, facilities, and equipment between animal groups reduces pathogen load. Controlling personnel and vehicle traffic between facilities limits inadvertent pathogen transfer.

Nutritional prevention focuses on maintaining optimal immune function through adequate dietary intake of all essential nutrients. Trace mineral supplementation with copper, zinc, selenium, and manganese supports immune cell function and antimicrobial defenses. Adequate vitamin E and vitamin A intake enhances respiratory tract integrity and immune responsiveness. Avoiding nutritional stress through consistent feed availability and appropriate diet transitions helps maintain resistance to respiratory disease. Preconditioning programs that establish calves on feed before sale improve nutritional status and stress resilience before the high-risk marketing period.

Management practices form the foundation of Mannheimia haemolytica prevention through stress reduction and maintenance of respiratory tract health. Preconditioning programs that include weaning, vaccination, deworming, and bunk training at the ranch of origin substantially reduce feedlot respiratory disease risk. Low-stress handling techniques and appropriate facility design minimize handling-related stress during processing and routine management. Adequate ventilation in housed cattle prevents accumulation of respiratory irritants and pathogens. Appropriate stocking density provides adequate space for normal behavior while reducing pathogen transmission.

Quarantine and testing protocols support disease prevention through controlled introduction of new animals. Incoming cattle should be isolated for observation and vaccination before mixing with established populations. The quarantine period allows expression of incubating infections acquired during transport or at previous locations. Testing may include evaluation for persistent BVDV infection, which creates ongoing immunosuppression and increased susceptibility to bacterial respiratory disease. Thorough health history documentation from source operations helps identify high-risk animals requiring enhanced monitoring or preventive treatment.

Daily management and monitoring for Mannheimia haemolytica prevention requires systematic observation of cattle for early signs of respiratory disease. Training personnel to recognize subtle behavioral changes, depression, nasal discharge, and respiratory distress enables early case identification when treatment is most likely to succeed. Establishing consistent observation routines, particularly during high-risk periods following arrival or stress events, ensures that developing cases are detected promptly. Pull protocols should define criteria for removing animals from home pens for closer evaluation and treatment, standardizing case identification across personnel.

Housing and environmental management significantly influence respiratory disease risk in cattle operations. Buildings should provide adequate ventilation to remove moisture, ammonia, and airborne pathogens while avoiding cold drafts on resting cattle. Dust control through bedding management, pen surface maintenance, and water application during dry conditions reduces respiratory tract irritation. Providing adequate shelter from weather extremes, including wind breaks on range operations, protects cattle from environmental stressors that predispose to disease. Pen design should facilitate easy observation, sorting, and treatment of sick animals.

Herd health programs provide a systematic framework for preventing and managing respiratory disease including Mannheimia haemolytica pneumonia. Veterinary consultation helps develop protocols appropriate for the specific operation, including vaccination schedules, arrival processing procedures, and treatment guidelines. Risk categorization of incoming cattle based on source, prior management, and physical condition guides the intensity of preventive interventions. Regular program review and adjustment based on health outcome data enables continuous improvement in disease prevention and treatment effectiveness.

Record keeping and monitoring systems generate the data needed for effective respiratory disease management. Individual animal identification enables tracking of disease events, treatments administered, and outcomes over time. Treatment records must include product used, dose, route, and date for food safety withdrawal time compliance. Morbidity and mortality data should be analyzed regularly to identify trends, evaluate treatment success rates, and compare outcomes to benchmarks. Necropsy findings should be recorded and reviewed to understand disease processes affecting the operation.

Economic considerations pervade all aspects of Mannheimia haemolytica management. Prevention programs require investment in vaccines, facilities, labor, and potentially price premiums for low-risk cattle, but typically provide positive returns through reduced treatment costs, mortality, and performance loss. Individual treatment decisions balance drug costs, labor, and subsequent performance against animal value and prognosis. Industry-wide, the substantial economic impact of respiratory disease drives ongoing research investment in improved vaccines, treatments, and management strategies. Operations benefit from tracking their own health costs and outcomes to inform management decisions and benchmark against industry standards.

All cattle breeds are susceptible to Mannheimia haemolytica pneumonia, with management factors playing a far greater role than genetics in determining disease risk. However, certain breed types may face elevated risk based on typical management systems and market channels. British beef breeds such as Angus and Hereford predominate in cow-calf production systems that market lightweight calves through auction markets, placing these animals in high-risk commingling situations. Continental breeds including Charolais, Limousin, and Simmental similarly face feedlot respiratory disease challenges based on production system involvement rather than inherent susceptibility.

Production type considerations influence disease risk more significantly than breed genetics. Beef calves marketed through traditional channels face the combined stresses of weaning, transport, and commingling that create conditions for Mannheimia haemolytica proliferation. Dairy beef calves, particularly Holstein bull calves entering calf ranches and veal operations, experience high disease pressure due to early separation from dams, commingling from multiple sources, and the physiological challenges facing young calves. Dairy heifers raised in commercial facilities similarly face elevated risk during the young calf period. Purebred operations with closed herds and limited outside introductions typically experience lower respiratory disease pressure.

Genetic selection efforts have explored potential for breeding cattle with enhanced disease resistance, though progress remains limited for respiratory disease specifically. Selection for overall immune competence, measured through various antibody and cell-mediated immunity tests, may indirectly improve respiratory disease resistance. Some Bos indicus influence appears to confer modest advantages in disease resistance under stressful conditions, though management improvements typically provide greater benefits than breed substitution. Current genetic selection strategies focus primarily on production and carcass traits, with health traits receiving increasing attention as economic selection indexes evolve to incorporate full cost accounting.

Commonly co-occurring conditions with Mannheimia haemolytica pneumonia include other components of the Bovine Respiratory Disease Complex. Viral respiratory infections with IBR, BVDV, BRSV, and PI3 frequently precede or accompany Mannheimia haemolytica infection, creating the immunosuppression and respiratory tract damage that enables bacterial invasion. Other bacterial pathogens including Pasteurella multocida, Histophilus somni, and Mycoplasma bovis often contribute to respiratory disease alongside Mannheimia haemolytica, either as co-infections or sequential invaders. Chronic cases may develop secondary complications including lung abscesses, pleuritis, and pericarditis.

Conditions with similar symptoms to Mannheimia haemolytica pneumonia require differentiation for appropriate treatment and management decisions. Pneumonia caused by other bacterial pathogens produces similar clinical signs, though laboratory diagnosis can identify the specific agents involved. Acute interstitial pneumonia, also called atypical interstitial pneumonia or fog fever, causes severe respiratory distress but has a distinct pathophysiology involving pulmonary edema and emphysema rather than bacterial infection. Aspiration pneumonia from improper oral medication administration affects the cranioventral lung lobes and may have a history of recent drenching or tubing.

Complications and sequelae of Mannheimia haemolytica pneumonia extend beyond the acute respiratory episode. Chronic pneumonia with ongoing respiratory compromise develops in cattle that survive severe acute disease but sustain permanent lung damage. Lung abscesses may form in areas of severe necrosis, creating ongoing infection sources and potential for septic spread. Pleuritis and pleural adhesions restrict lung expansion and impair respiratory efficiency. Myocarditis and pericarditis occur when infection spreads to cardiac structures. Survivors of severe pneumonia often demonstrate chronic ill-thrift with reduced growth rates and impaired feed efficiency throughout their remaining productive life.